Honorable Lois W. Kolkhorst, Chair, Senate Committee on Health & Human Services
FROM:
Jerry McGinty, Director, Legislative Budget Board
IN RE:
SB2212 by Blanco (Relating to the disclosure by a pharmacy to a patient of certain price information for a drug or biological product.), As Introduced
No significant fiscal implication to the State is anticipated.
Based on the analysis of the Board of Pharmacy, duties and responsibilities associated with implementing the provisions of the bill could be accomplished by utilizing existing resources.
Local Government Impact
No significant fiscal implication to units of local government is anticipated.